查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年控制释放给药市场预测：按类型、释放机制、应用和地区进行的全球分析
市场调查报告书
商品编码
1383415

2030 年控制释放给药市场预测：按类型、释放机制、应用和地区进行的全球分析

Controlled Release Drug Delivery Market Forecasts to 2030 - Global Analysis By Type, By Release Mechanism, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球控制释放给药市场规模为556.9亿美元，预计到2030年将达到1,278亿美元，预测期内年复合成长率为12.6%。

控制释放药物递送是一种製药技术，其重点是在较长时间内以即时和受控的方式将药物给药体内，这与在给药后迅速释放整个剂量的立即释放製剂相反。控制释放药物输送系统旨在实现特定的治疗目标，例如维持血液中恆定的药物浓度、最大限度地减少副作用、提高患者用药医嘱遵从性以及提高整体治疗效果。仅此而已。

根据《国家健康科学》公布的统计数据，2021年英国将有约117万人被诊断出患有慢性阻塞性肺病（COPD），占总人口的1.9%。

慢性病增加

由于慢性病盛行率上升，控制释放给药市场不断成长。随着糖尿病、心血管疾病和神经系统疾病等疾病变得越来越普遍，对持续和标靶给药系统的需求不断增加。这些技术具有提高患者依从性、减少给药频率和最大限度减少副作用等优点。透过确保药物的稳定和受控释放，这些输送系统在有效管理慢性疾病方面发挥关键作用。随着全球慢性病负担持续增加，对先进控制释放给药解决方案的需求预计将大幅成长。

比传统方法成本更高

开发和製造控制释放系统需要复杂的技术、专用材料和广泛的研究，这增加了製造成本。结果，付款人、医疗保健系统和患者都承受着成本增加的负担。控制释放系统具有提高患者依从性和减少副作用的优点，但其高昂的成本使一些患者无法使用它们，这可能会阻碍市场扩张。

老年人和儿童人口增加

随着人口老化的增加，治疗慢性疾病的长期药物管理的需求也随之增加。同样，在小儿科，控制释放系统透过最大限度地减少精确给药和频繁给药的需要来确保安全性和合规性。为了减少副作用并改善治疗结果，这些病患小组经常需要个体化和一致的药物传递。因此，随着对满足年轻人和老年人特定治疗需求的控制释放药物输送解决方案的需求不断增加，市场正在扩大。

严格的法规核准

严格的法规核准对控制释放给药市场构成重大威胁。开发和商业化这些尖端的药物输送系统需要严格的测试并遵守复杂的法规要求，这既耗时又昂贵。获得核准的这种延迟可能会阻碍市场成长和创新，抑制投资，并限制患者获得改进的治疗方法。

COVID-19 的影响：

COVID-19大流行控制释放药物输送市场产生了重大影响。大流行期间对药品和抗病毒治疗药物的需求激增，刺激了控制释放药物传递系统的开发和采用。然而，挑战包括全球供应链中断、临床试验减少以及医疗资源重新分配。此外，在此期间，对研究和开发的关注以及对远端患者监护以对抗病毒的需求加速了控制释放技术的创新和采用。

预计目标交付部分在预测期内将是最大的

在控制释放给药市场中，标靶给药领域预计将占据最大的市场占有率。其背景是对个人化医疗的日益重视以及对准确靶向体内特定区域和细胞的药物输送系统的需求不断增长。药物传输具有减少副作用、增强药物疗效及改善患者治疗效果等优点。这对于治疗癌症等疾病尤其重要，因为局部和受控的药物释放非常有效。这些因素极大地推动了该细分市场的成长。

在预测期内，口服给药系统领域预期复合年复合成长率最高

在控制释放给药市场中，口服控制释放给药系统领域预计将呈现最高的成长率。口服给药因其方便、非侵入性而受到患者的青睐，需求量不断增加。此外，製药技术的不断改进使得更有效的控制释放系统成为可能。由于其能够提高患者依从性、减少给药频率并提供长期稳定的药物释放，该市场可能会显着成长。

占比最大的地区：

预计在预测期内，北美将保持其在控制释放给药市场的主导地位。该地区发达的製药业、发达的医疗基础设施以及慢性病的高盛行率正在推动对先进给药技术的需求。此外，研发方面的大量投资和强有力的法律规范正在支持控制释放药物的创新和核准。该地区庞大的患者群体和主要市场参与企业的存在也有助于其在未来年度的优势。

复合年复合成长率最高的地区：

由于人口增长、医疗保健基础设施的发展以及中阶的增长和医疗保健机会的改善，对先进药物输送系统的需求不断增加，预计亚太地区的控制释放药物输送市场将在预测期内增长。最高的增长。在亚太地区，糖尿病和癌症等慢性病的流行正在推动控制释放药物的采用，以实现更好的管理。此外，增加研发投资也有助于该地区强劲的成长潜力，使其成为全球市场的强大参与者。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球控制释放给药市场：依技术分类

  • 阿尔斯特技术
  • 凝聚
  • 植入
  • 脂质体
  • 微胶囊化
  • 电子机械技术
  • 定向投放
  • 经皮的
  • 其他技术

第6章全球控制释放给药市场：依释放机制分类

  • 基于聚合物的系统
  • 回馈法规给药系统
  • 微储库分区控制给药系统
  • 活化调节的药物递送系统
    • 动态压力驱动
    • 磁力驱动
    • 机械操作的
    • 渗透激活
    • 蒸气压活化
  • 化学活化
    • 酶激活
    • 水解活化
    • pH值活化
  • 其他释放机制

第7章全球控制释放给药市场：依应用分类

  • 定量吸入器
  • 药物释放型支架
  • 点滴帮浦
  • 可注射的
  • 口服控释给药系统
  • 经皮吸收贴片和眼科贴剂
  • 其他用途

第8章全球控制释放给药市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Abbott Laboratories
  • Alkermes plc
  • Aradigm Corporation
  • Bayer HealthCare LLC
  • Bracco SpA
  • Bristol-Myers Squibb
  • Capsugel
  • Coating Place, Inc.
  • Corium International, Inc.
  • Depomed, Inc.
  • GE Healthcare
  • GSK plc
  • Guerbet Group
  • Johnson and Johnson Ltd.
  • Medtronic AG
  • Merck and Co.Inc.
  • Mylan NV
  • Orbis Biosciences.Inc.
  • Pfizer, Inc.
  • Roche Holding AG
  • Sanofi
  • Sino Medical-Device Technology Co.
  • Sun Pharmaceuticals Industries Ltd
  • Ulrich GmbH & Co. KG
  • Vectura Group plc
Product Code: SMRC24264

According to Stratistics MRC, the Global Controlled Release Drug Delivery Market is accounted for $55.69 billion in 2023 and is expected to reach $127.80 billion by 2030 growing at a CAGR of 12.6% during the forecast period. Controlled release drug delivery is a pharmaceutical technology focused on administering medications to the body in a gradual and regulated manner over an extended period, in contrast to immediate-release formulations that deliver the entire dose rapidly upon administration. The goal of controlled-release drug delivery systems is to achieve specific therapeutic objectives, such as maintaining consistent drug levels in the bloodstream, minimizing adverse effects, enhancing patient adherence, and improving the overall effectiveness of treatment.

According to statistics published by National Health Science, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2021, accounting for 1.9% of the total population.

Market Dynamics:

Driver:

Rising incidence of chronic diseases

The controlled release drug delivery market is seeing growth propelled by the escalating prevalence of chronic diseases. With conditions like diabetes, cardiovascular disorders, and neurological ailments becoming more prevalent, there is an increased demand for sustained and targeted drug delivery systems. These technologies offer benefits such as improved patient compliance, reduced dosing frequency, and minimized side effects. By ensuring a steady and controlled release of medications, these delivery systems play a crucial role in managing chronic conditions effectively. As the global burden of chronic diseases continues to rise, the demand for advanced controlled-release drug delivery solutions is expected to expand significantly.

Restraint:

Higher cost compared to the conventional method

Production costs are increased by the need for complex technologies, specialty materials, and extensive research when developing and manufacturing controlled release systems. As a result, payers, healthcare systems, and patients all bear the increased costs. Although there are benefits associated with controlled release systems, such as better patient compliance and fewer side effects, their higher cost may prevent some patients from using them and thus impede market expansion.

Opportunity:

Growing geriatric and pediatric population

The need for extended medication management to treat chronic health conditions is growing as the elderly population grows. In Similar to this, controlled release systems in pediatrics ensure safety and compliance by offering precise dosing and minimizing the need for frequent administration. To reduce side effects and improve treatment outcomes, these patient groups frequently need individualized, consistent medication delivery. As a result, the market is expanding due to the growing demand for controlled release drug delivery solutions that meet the specific therapeutic needs of both younger and older populations.

Threat:

Stringent regulatory approvals

Stringent regulatory approvals pose a significant threat to the controlled release drug delivery market. Developing and marketing these advanced drug delivery systems requires rigorous testing and compliance with complex regulatory requirements, which can be time-consuming and costly. Such delays in obtaining approvals can hinder the market's growth and innovation, deterring investment and potentially limiting patient access to improved therapies.

COVID-19 Impact:

The COVID-19 pandemic significantly influenced the controlled release drug delivery market. The increased demand for pharmaceuticals and antiviral treatments surged during the pandemic, driving the development and adoption of controlled-release drug delivery systems. However, disruptions in the global supply chain, reduced clinical trials, and healthcare resource reallocation posed challenges. Additionally, the focus on research and development to combat the virus and the need for remote patient monitoring accelerated the innovation and adoption of controlled release technologies during this period.

The targeted delivery segment is expected to be the largest during the forecast period

The targeted delivery segment is anticipated to capture the largest market share in the controlled drug delivery market. This prominence is attributed to the growing emphasis on personalized medicine and the need for drug delivery systems that can precisely target specific sites or cells in the body. Targeted delivery offers the advantages of reduced side effects, enhanced drug efficacy, and improved patient outcomes. It is particularly crucial in the treatment of conditions like cancer, where localized and controlled drug release can be highly effective. These factors significantly drive the segment's growth.

The oral controlled-drug delivery systems segment is expected to have the highest CAGR during the forecast period

In the controlled release drug delivery market, the oral controlled-drug delivery systems segment is anticipated to grow at the highest rate. Patients prefer the oral route of drug administration because it is convenient and non-invasive, which has increased demand for it. Moreover, more efficient oral controlled-release systems have been made possible by continuous improvements in pharmaceutical technology. The market is well-positioned for substantial growth due to its ability to improve patient compliance, lower the frequency of doses, and deliver a consistent release of medications over time.

Region with largest share:

North America is projected to sustain its leading position in the controlled release drug delivery market during the forecast period. The region has a well-established pharmaceutical industry, a robust healthcare infrastructure, and a high prevalence of chronic diseases, driving the demand for advanced drug delivery technologies. Additionally, substantial investments in research and development, coupled with strong regulatory frameworks, encourage innovation and the approval of controlled-release drug products. The region's large patient population, along with the presence of key market players, contributes to its dominance in the coming years.

Region with highest CAGR:

The Asia Pacific region is estimated to witness the highest growth in the controlled release drug delivery market during the forecast period owing to the region's rising population, increasing healthcare infrastructure, and a growing middle class with greater access to healthcare, which are driving demand for advanced drug delivery systems. The prevalence of chronic diseases in Asia Pacific, such as diabetes and cancer, is boosting the adoption of controlled-release drugs for better management. Additionally, the increasing investments in research and development contribute to the region's significant growth potential, making it a prominent player in the global market.

Key players in the market

Some of the key players in Controlled Release Drug Delivery market include: Abbott Laboratories, Alkermes plc, Aradigm Corporation, Bayer HealthCare LLC, Bracco S.p.A., Bristol-Myers Squibb, Capsugel, Coating Place, Inc., Corium International, Inc., Depomed, Inc., GE Healthcare, GSK plc, Guerbet Group, Johnson and Johnson Ltd., Medtronic AG, Merck and Co.Inc., Mylan N.V., Orbis Biosciences.Inc., Pfizer, Inc., Roche Holding AG, Sanofi, Sino Medical-Device Technology Co., Sun Pharmaceuticals Industries Ltd, Ulrich GmbH & Co. KG and Vectura Group plc.

Key Developments:

In April 2023, Researchers at the Indian Institute of Technology Guwahati (IIT-G) have developed liquid marbles using nano clay that can be pre-programmed for drug delivery and cascade chemical reactions. The IIT-G team has used the liquid marbles approach for the controlled release of drugs and programmed chemical reaction. The team has engineered liquid marbles to have a 'time bomb' type release effect and to carry out a spontaneous chemical reaction. The nano clay marbles were made of a shell of nanoclay that holds the liquid. To programme the marbles for timed release of the content, the researchers modified the nanoclay with chemical groups that were either water-loving (hydrophilic) or waterhating (hydrophobic).

In December 2022, InSitu Biologics, Inc. is pleased to announce that it has entered into an agreement with the Mayo Foundation for Medical Education and Research to further develop its prolonged-release drug delivery technology for anti-cancer therapeutics.

Technologies Covered:

  • Wurster Technique
  • Coacervation
  • Implants
  • Liposomes
  • Micro Encapsulation
  • Microelectromechanical Technology
  • Targeted Delivery
  • Transdermal
  • Other Technologies

Release Mechanisms Covered:

  • Polymer Based Systems
  • Feedback Regulated Drug Delivery Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated
  • Other Release Mechanisms

Applications Covered:

  • Metered Dose Inhalers
  • Drug Eluting Stents
  • Infusion Pumps
  • Injectable
  • Oral Controlled-drug delivery Systems
  • Transdermal and Ocular Patches
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Controlled Release Drug Delivery Market, By Technology

  • 5.1 Introduction
  • 5.2 Wurster Technique
  • 5.3 Coacervation
  • 5.4 Implants
  • 5.5 Liposomes
  • 5.6 Micro Encapsulation
  • 5.7 Microelectromechanical Technology
  • 5.8 Targeted Delivery
  • 5.9 Transdermal
  • 5.10 Other Technologies

6 Global Controlled Release Drug Delivery Market, By Release Mechanism

  • 6.1 Introduction
  • 6.2 Polymer Based Systems
  • 6.3 Feedback Regulated Drug Delivery Systems
  • 6.4 Micro Reservoir Partition Controlled Drug Delivery Systems
  • 6.5 Activation-modulated Drug Delivery Systems
    • 6.5.1 Hydrodynamic Pressure Activated
    • 6.5.2 Magnetically Activated
    • 6.5.3 Mechanically Activated
    • 6.5.4 Osmotic Pressure Activated
    • 6.5.5 Vapor Pressure Activated
  • 6.6 Chemically Activated
    • 6.6.1 Enzyme Activated
    • 6.6.2 Hydrolysis Activated
    • 6.6.3 pH Activated
  • 6.7 Other Release Mechanisms

7 Global Controlled Release Drug Delivery Market, By Application

  • 7.1 Introduction
  • 7.2 Metered Dose Inhalers
  • 7.3 Drug Eluting Stents
  • 7.4 Infusion Pumps
  • 7.5 Injectable
  • 7.6 Oral Controlled-drug delivery Systems
  • 7.7 Transdermal and Ocular Patches
  • 7.8 Other Applications

8 Global Controlled Release Drug Delivery Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alkermes plc
  • 10.3 Aradigm Corporation
  • 10.4 Bayer HealthCare LLC
  • 10.5 Bracco S.p.A.
  • 10.6 Bristol-Myers Squibb
  • 10.7 Capsugel
  • 10.8 Coating Place, Inc.
  • 10.9 Corium International, Inc.
  • 10.10 Depomed, Inc.
  • 10.11 GE Healthcare
  • 10.12 GSK plc
  • 10.13 Guerbet Group
  • 10.14 Johnson and Johnson Ltd.
  • 10.15 Medtronic AG
  • 10.16 Merck and Co.Inc.
  • 10.17 Mylan N.V.
  • 10.18 Orbis Biosciences.Inc.
  • 10.19 Pfizer, Inc.
  • 10.20 Roche Holding AG
  • 10.21 Sanofi
  • 10.22 Sino Medical-Device Technology Co.
  • 10.23 Sun Pharmaceuticals Industries Ltd
  • 10.24 Ulrich GmbH & Co. KG
  • 10.25 Vectura Group plc

List of Tables

  • Table 1 Global Controlled Release Drug Delivery Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Controlled Release Drug Delivery Market Outlook, By Technology (2021-2030) ($MN)
  • Table 3 Global Controlled Release Drug Delivery Market Outlook, By Wurster Technique (2021-2030) ($MN)
  • Table 4 Global Controlled Release Drug Delivery Market Outlook, By Coacervation (2021-2030) ($MN)
  • Table 5 Global Controlled Release Drug Delivery Market Outlook, By Implants (2021-2030) ($MN)
  • Table 6 Global Controlled Release Drug Delivery Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 7 Global Controlled Release Drug Delivery Market Outlook, By Micro Encapsulation (2021-2030) ($MN)
  • Table 8 Global Controlled Release Drug Delivery Market Outlook, By Microelectromechanical Technology (2021-2030) ($MN)
  • Table 9 Global Controlled Release Drug Delivery Market Outlook, By Targeted Delivery (2021-2030) ($MN)
  • Table 10 Global Controlled Release Drug Delivery Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 11 Global Controlled Release Drug Delivery Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 12 Global Controlled Release Drug Delivery Market Outlook, By Release Mechanism (2021-2030) ($MN)
  • Table 13 Global Controlled Release Drug Delivery Market Outlook, By Polymer Based Systems (2021-2030) ($MN)
  • Table 14 Global Controlled Release Drug Delivery Market Outlook, By Feedback Regulated Drug Delivery Systems (2021-2030) ($MN)
  • Table 15 Global Controlled Release Drug Delivery Market Outlook, By Micro Reservoir Partition Controlled Drug Delivery Systems (2021-2030) ($MN)
  • Table 16 Global Controlled Release Drug Delivery Market Outlook, By Activation-modulated Drug Delivery Systems (2021-2030) ($MN)
  • Table 17 Global Controlled Release Drug Delivery Market Outlook, By Hydrodynamic Pressure Activated (2021-2030) ($MN)
  • Table 18 Global Controlled Release Drug Delivery Market Outlook, By Magnetically Activated (2021-2030) ($MN)
  • Table 19 Global Controlled Release Drug Delivery Market Outlook, By Mechanically Activated (2021-2030) ($MN)
  • Table 20 Global Controlled Release Drug Delivery Market Outlook, By Osmotic Pressure Activated (2021-2030) ($MN)
  • Table 21 Global Controlled Release Drug Delivery Market Outlook, By Vapor Pressure Activated (2021-2030) ($MN)
  • Table 22 Global Controlled Release Drug Delivery Market Outlook, By Chemically Activated (2021-2030) ($MN)
  • Table 23 Global Controlled Release Drug Delivery Market Outlook, By Enzyme Activated (2021-2030) ($MN)
  • Table 24 Global Controlled Release Drug Delivery Market Outlook, By Hydrolysis Activated (2021-2030) ($MN)
  • Table 25 Global Controlled Release Drug Delivery Market Outlook, By pH Activated (2021-2030) ($MN)
  • Table 26 Global Controlled Release Drug Delivery Market Outlook, By Other Release Mechanisms (2021-2030) ($MN)
  • Table 27 Global Controlled Release Drug Delivery Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 Global Controlled Release Drug Delivery Market Outlook, By Metered Dose Inhalers (2021-2030) ($MN)
  • Table 29 Global Controlled Release Drug Delivery Market Outlook, By Drug Eluting Stents (2021-2030) ($MN)
  • Table 30 Global Controlled Release Drug Delivery Market Outlook, By Infusion Pumps (2021-2030) ($MN)
  • Table 31 Global Controlled Release Drug Delivery Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 32 Global Controlled Release Drug Delivery Market Outlook, By Oral Controlled-drug delivery Systems (2021-2030) ($MN)
  • Table 33 Global Controlled Release Drug Delivery Market Outlook, By Transdermal and Ocular Patches (2021-2030) ($MN)
  • Table 34 Global Controlled Release Drug Delivery Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.